Enovis (ENOV) Income from Non-Controlling Interests (2012 - 2026)
Enovis (ENOV) posted quarterly Income from Non-Controlling Interests of $314000.0 for Q2 2026, up 20.31% year-over-year from $261000.0 in Q2 2025, and up 132.59% quarter-over-quarter from $135000.0 in Q4 2025.
Enovis (ENOV) Income from Non-Controlling Interests (2012 - 2026) Analysis & Trends
Enovis (ENOV) has reported Income from Non-Controlling Interests for 15 consecutive years, with $314000.0 the latest figure, recorded in Q2 2026.
- In Q2 2026, Income from Non-Controlling Interests rose 20.31% year-over-year to $314000.0; the TTM figure through Apr 2026 stood at $873000.0 (up 11.49% YoY), while the FY2025 annual figure was $820000.0, up 20.77% from the prior year.
- Income from Non-Controlling Interests improved to $314000.0 in Q2 2026 per ENOV's latest filing, from $135000.0 in the prior quarter.
- Across five years, Income from Non-Controlling Interests topped out at $314000.0 in Q2 2026 and bottomed at $34000.0 in Q4 2022.
- Historically, Income from Non-Controlling Interests has averaged $176266.7 across 5 years, with a median of $182000.0 in 2023.
- Annual changes were most pronounced in 2022 — Income from Non-Controlling Interests tumbled 84.26% — and 2024, when it surged 547.5%.
- Enovis' Income from Non-Controlling Interests stood at $34000.0 in 2022, then soared by 241.18% to $116000.0 in 2023, then rose by 18.1% to $137000.0 in 2024, then decreased by 1.46% to $135000.0 in 2025, then surged by 132.59% to $314000.0 in 2026.
- Business Quant data shows ENOV's Income from Non-Controlling Interests at $314000.0 in Q2 2026, $135000.0 in Q4 2025, and $233000.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | - |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | - |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 16.00 Mn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | -2.00 Mn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | -500,000.00 |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 13.00 Mn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 2.32 Mn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 900,000.00 |
| 10 | Enovis | 1.50 Bn | 1.48 Bn | 359.25 Mn | 154,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jul 3, 2026 | 154,000.00 |
| Apr 3, 2026 | 314,000.00 |
| Dec 31, 2025 | 135,000.00 |
| Oct 3, 2025 | 233,000.00 |
| Jul 4, 2025 | 191,000.00 |
| Apr 4, 2025 | 261,000.00 |
| Dec 31, 2024 | 137,000.00 |
| Sep 27, 2024 | 259,000.00 |
| Jun 28, 2024 | 126,000.00 |
| Mar 29, 2024 | 157,000.00 |
| Dec 31, 2023 | 116,000.00 |
| Sep 29, 2023 | 40,000.00 |
| Jun 30, 2023 | 182,000.00 |
| Mar 31, 2023 | 192,000.00 |
| Dec 31, 2022 | 34,000.00 |
| Apr 1, 2022 | 267,000.00 |
| Dec 31, 2021 | 216,000.00 |
| Oct 1, 2021 | 191,000.00 |
| Jul 2, 2021 | 705,000.00 |
| Apr 2, 2021 | 876,000.00 |